Since 1992, Doylestown Hospital’s membership in the University of Pennsylvania (Penn) Cancer Network has continued to enhance the scope, strength and prestige of its cancer program and its level of patient care, clinical research and education.

“We partner with institutions, such as Doylestown Hospital, that already have an excellent reputation in their community and then work with them on the development or expansion of their cancer program,” says Jeanne M. Rogers, RN, MEd, Associate Executive Director of the Abramson Cancer Center of the University of Pennsylvania and Administrative Director of the University of Pennsylvania Cancer Network.

“We complement the excellent programs and services offered at Doylestown Hospital with highly specialized clinical services, such as bone marrow transplantation and Phase I clinical research studies,” Ms. Rogers says. “Our goal is to provide a seamless system of care for patients and their families.”

The Abramson Cancer Center of the University of Pennsylvania is one of the nation’s leading cancer centers. It is among an elite group of cancer centers in the county designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center.

Penn established the Cancer Network in 1991 to bring the latest research, preventive, diagnostic and treatment approaches to the community. It is one of the largest networks of its kind in the country, with 22 members in eastern Pennsylvania and central and southern New Jersey.

“Doylestown Hospital has an excellent cancer program, and we are proud to have them as a member of the University of Pennsylvania Cancer Network,” Ms. Rogers concludes.